Only two cases of patients with Peyronies disease with complete plaque regression after treatment have been described in literature
Dihydroergotamine mesylate nasal spray, 5-HT1 agonists (e.g., sumatriptan), ergotamine-containing or ergot-type medications or methysergide should not be used within 24 hours of each other
Direct Receptor-Mediated Effects : While preclinical studies suggest GLP-1 receptors may be present in bone tissue, the clinical relevance of direct receptor activation in human bone cells remains uncertain and controversial
Some observational data and animal model research has suggested GLP-1 receptor agonists may have direct bone-protective signaling effects that could modulate long-term fracture risk
Shiraishi, K
Treatment Duration: 15-30 minutes Perfect For: Anti-aging support, cognitive enhancement, chronic fatigue, athletic performance optimization, addiction recovery support, brain fog, metabolic health, executives and high-performers Treatment Duration: 15-20 minutes Perfect For: Acute migraines, chronic headaches, cluster headaches, tension headaches, nausea and vomiting, light/sound sensitivity, medication-resistant migraines Affordable Add-On: Perfect as a standalone treatment or combined with other IVs for enhanced benefits
